Family · Pharmaceutical analytical standards
Cotrimoxazole
A combination of trimethoprim and sulfamethoxazole, which block two successive steps of folate synthesis in bacteria: born in the late 1960s, when their synergy was described, it is used against urinary and respiratory infections and Pneumocystis pneumonia. This family brings together the active ingredient and labelled standards.
Did you know?In the tablets the two active ingredients are in a 1:5 ratio, but in blood and tissues this becomes about 1:20: exactly the ratio that gives peak synergy.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
